Clinical Trial Update: Biocell Natural Killer Mixture in Diffuse Large B Cell Lymphoma (DLBCL) Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for Biocell Natural Killer Mixture in diffuse large B-cell lymphoma (DLBCL) is ongoing, sponsored by NKBio Co. Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Biocell Natural Killer Mixture

Snippet

Sponsor: NKBio Co.Ltd. | Conditions: Diffuse Large B-cell Lymphoma | Phase 3 | Status: UNKNOWN